loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Gemcabene

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Gemcabene

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gemphire cuts 33% of staff, including CFO, CMO
    Gemphire cuts 33% of staff, including CFO, CMO

    25 Sep 2018

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gemphire-cuts-33-staff-including-cfo-cmo

    Amirah Al Idrus FIERCE BIOTECH
    25 Sep 2018
    Share Share
    In back-to-back trial disasters, Gemphire now says it shuttered a trial
    In back-to-back trial disasters, Gemphire now says it shuttered a trial

    10 Aug 2018

    // John Carroll ENDPTS

    https://endpts.com/in-back-to-back-trial-disasters-gemphire-now-says-it-shuttered-a-trial-after-seeing-patients-fatty-liver-disease-get-worse/

    John Carroll ENDPTS
    10 Aug 2018
    Share Share
    Battered Gemphire shares soar on new triglyceride data, but there’s a lot left
    Battered Gemphire shares soar on new triglyceride data, but there’s a lot left

    30 Jun 2018

    // John Carroll ENDPTS

    https://endpts.com/battered-gemphire-shares-soar-on-new-triglyceride-data-but-theres-a-lot-left-to-prove/

    John Carroll ENDPTS
    30 Jun 2018
    Share Share